IRD vs MTB · rev $11.0M vs P/E 12, $30.99B cap
Opus Genetics, Inc. (IRD) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
MTB does not have a complete income-statement cache yet.
IRD currently screens at market cap $35.7M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the IRD and MTB stock pages for the full models.
Not investment advice.